Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009

International Journal of Antimicrobial Agents

Volumn 37, Issue 6, 2011, Pages 562-566

  Dowzicky, Michael J ^a   Chmelařová, Eva ^b  

^a PFIZER INC   (United States)

^b Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

Author keywords

Antimicrobial; Linezolid; Resistance; Surveillance; Tigecycline

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CZECH REPUBLIC; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 79955466139     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.02.004     Document Type: Article

References (15)

1. D.J. Anderson, K.S. Kaye, L.F. Chen, K.E. Schmader, Y. Choi, and R. Sloane Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study PLoS One 4 2009 e8305
2. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. Document M7-A6. Wayne, PA: NCCLS; 2003.
3. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
4. ® product insert. Philadelphia, PA: Pfizer Inc; 2010. http://www.pfizerpro.com/hcp/tygacil [accessed 20 October 2010].
5. S.D. Putnam, H.S. Sader, D.J. Farrell, and R.N. Jones Sustained antimicrobial activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from United States medical centers from 2004 through 2008 J Chemother 22 2010 13 16
6. R.N. Jones, S. Kohno, Y. Ono, J.E. Ross, and K. Yanagihara ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries Diagn Microbiol Infect Dis 64 2009 191 201
7. D.J. Farrell, J.D. Turnidge, J. Bell, H.S. Sader, and R.N. Jones The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008) J Infect 60 2010 440 451
8. M.W. Garrison, R. Mutters, and M.J. Dowzicky In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007 Diagn Microbiol Infect Dis 65 2009 288 299
9. S.K. Bouchillon, J.R. Iredell, T. Barkham, K. Lee, and M.J. Dowzicky Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) Int J Antimicrob Agents 33 2009 130 136
10. M.H. Scheetz, S.A. Knechtel, M. Malczynski, M.J. Postelnick, and C. Qi Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption Antimicrob Agents Chemother 52 2008 2256 2259 (Pubitemid 351758573)
11. S. Ono, T. Muratani, and T. Matsumoto Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis Antimicrob Agents Chemother 49 2005 2954 2958 (Pubitemid 40917616)
12. M.A. Kainer, R.A. Devasia, T.F. Jones, B.P. Simmons, K. Melton, and S. Chow Response to emerging infection leading to outbreak of linezolid-resistant enterococci Emerg Infect Dis 13 2007 1024 1030 (Pubitemid 47048074)
13. R.N. Jones, J.E. Ross, J.M. Bell, U. Utsuki, I. Fumiaki, and I. Kobayashi Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008 Diagn Microbiol Infect Dis 65 2009 404 413
14. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
15. Centers for Disease Control and Prevention (CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae - United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2008;57:1353-5.